Search research articles
Contact Us
Filters
Showing results (181-190 of 262) with videos related to
Page
of 27
Sort By:
Journal of Environmental and Public Health
|
May 17, 2021
Cost-Effectiveness and Budget Impact Analyses of Pneumococcal Vaccination in Indonesia
Auliya A Suwantika, Neily Zakiyah, Rizky Abdulah, et al.
The Oncologist
|
February 8, 2024
Exploring the Landscape of Immune Checkpoint Inhibitor-Induced Adverse Events Through Big Data Mining of Pan-Cancer Clinical Trials
Muhammad Zaki Hidayatullah Fadlullah, Ching-Nung Lin, Samuel Coleman, et al.
Natural Product Communications
|
July 10, 2010
Purification and biochemical characterization of alkaline serine protease from Caesalpinia bonducella
Hidayatullah Khan, Irshad Ali, Arif-ullah Khan, et al.
Molecular Cancer Research : MCR
|
June 14, 2013
Snail cooperates with KrasG12D to promote pancreatic fibrosis
Mario A Shields, Kazumi Ebine, Vaibhav Sahai, et al.
International Journal of Molecular Sciences
|
September 5, 2019
Quercetin Enhances the Anti-Tumor Effects of BET Inhibitors by Suppressing hnRNPA1
Thao N D Pham, Sophie Stempel, Mario A Shields, et al.
Molecular Cancer Therapeutics
|
August 8, 2006
Enzastaurin (LY317615), a protein kinase Cbeta inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines
Mujahid A Rizvi, Kulsoom Ghias, Katharine M Davies, et al.
Biochemical and Biophysical Research Communications
|
September 24, 2018
Corrigendum to 'The C-terminus of ubiquitin plays a critical role in deamidase Lpg2148 recognition.' [Biochem. Biophys. Res. Commun. 503(4), 18 September 2018, 2943-2948]
Min Zhu, Xiuchang Ma, Yongxiang Gao, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2025
Resistance to the KRAS<sup>G12D</sup> Inhibitor MRTX1133 is Associated with Increased Sensitivity to BET Inhibition
Daniel R Principe, Jeffrey H Becker, Anastasia E Metropulos, et al.
Molecular Cancer Therapeutics
|
November 18, 2018
Induction of MNK Kinase-dependent eIF4E Phosphorylation by Inhibitors Targeting BET Proteins Limits Efficacy of BET Inhibitors
Thao N D Pham, Krishan Kumar, Brian T DeCant, et al.
Molecular Cancer Therapeutics
|
May 9, 2014
BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen
Vaibhav Sahai, Krishan Kumar, Lawrence M Knab, et al.
Page
of 27
Search research articles
Search
Showing results (181-190 of 262) with videos related to
Sort By:
Page
of 27
Journal of Environmental and Public Health
|
May 17, 2021
Cost-Effectiveness and Budget Impact Analyses of Pneumococcal Vaccination in Indonesia
Auliya A Suwantika, Neily Zakiyah, Rizky Abdulah, et al.
The Oncologist
|
February 8, 2024
Exploring the Landscape of Immune Checkpoint Inhibitor-Induced Adverse Events Through Big Data Mining of Pan-Cancer Clinical Trials
Muhammad Zaki Hidayatullah Fadlullah, Ching-Nung Lin, Samuel Coleman, et al.
Natural Product Communications
|
July 10, 2010
Purification and biochemical characterization of alkaline serine protease from Caesalpinia bonducella
Hidayatullah Khan, Irshad Ali, Arif-ullah Khan, et al.
Molecular Cancer Research : MCR
|
June 14, 2013
Snail cooperates with KrasG12D to promote pancreatic fibrosis
Mario A Shields, Kazumi Ebine, Vaibhav Sahai, et al.
International Journal of Molecular Sciences
|
September 5, 2019
Quercetin Enhances the Anti-Tumor Effects of BET Inhibitors by Suppressing hnRNPA1
Thao N D Pham, Sophie Stempel, Mario A Shields, et al.
Molecular Cancer Therapeutics
|
August 8, 2006
Enzastaurin (LY317615), a protein kinase Cbeta inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines
Mujahid A Rizvi, Kulsoom Ghias, Katharine M Davies, et al.
Biochemical and Biophysical Research Communications
|
September 24, 2018
Corrigendum to 'The C-terminus of ubiquitin plays a critical role in deamidase Lpg2148 recognition.' [Biochem. Biophys. Res. Commun. 503(4), 18 September 2018, 2943-2948]
Min Zhu, Xiuchang Ma, Yongxiang Gao, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2025
Resistance to the KRAS<sup>G12D</sup> Inhibitor MRTX1133 is Associated with Increased Sensitivity to BET Inhibition
Daniel R Principe, Jeffrey H Becker, Anastasia E Metropulos, et al.
Molecular Cancer Therapeutics
|
November 18, 2018
Induction of MNK Kinase-dependent eIF4E Phosphorylation by Inhibitors Targeting BET Proteins Limits Efficacy of BET Inhibitors
Thao N D Pham, Krishan Kumar, Brian T DeCant, et al.
Molecular Cancer Therapeutics
|
May 9, 2014
BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen
Vaibhav Sahai, Krishan Kumar, Lawrence M Knab, et al.
Page
of 27